Standard Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-11-2024
- Paid Up Capital ₹ 0.10 M
as on 03-11-2024
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 58.25%
(FY 2023)
- Profit -758.02%
(FY 2023)
- Ebitda -496.33%
(FY 2023)
- Net Worth -690.97%
(FY 2023)
- Total Assets -79.18%
(FY 2023)
About Standard Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Dubey and Radhika Bagla serve as directors at the Company.
- CIN/LLPIN
U85110UP2020PTC128297
- Company No.
128297
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2020
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Standard Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Dubey  | Director | Current | |
| Radhika Bagla | Director | 04-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Standard Diagnostics.
Standard Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.25% increase. The company also saw a substantial fall in profitability, with a 758.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 690.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Standard Diagnostics?
In 2023, Standard Diagnostics had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Redcliffe Lifetech Private LimitedActive 3 years 10 monthsAshish Dubey and Radhika Bagla are mutual person
Scitechesy Research And Technology Private LimitedActive 3 years 2 monthsAshish Dubey is a mutual person
- Redcliffe Lifescience Private LimitedActive 7 years 3 months
Ashish Dubey and Radhika Bagla are mutual person
- Redcliffe Life Images Private LimitedActive 3 years 2 months
Ashish Dubey and Radhika Bagla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Standard Diagnostics?
Standard Diagnostics has a workforce of 353 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Standard Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Standard Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
